1. Home
  2. CVR vs ADVB Comparison

CVR vs ADVB Comparison

Compare CVR & ADVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Chicago Rivet & Machine Co.

CVR

Chicago Rivet & Machine Co.

N/A

Current Price

$14.53

Market Cap

10.4M

Sector

Industrials

ML Signal

N/A

ADVB

Advanced Biomed Inc.

HOLD

Current Price

$0.35

Market Cap

8.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CVR
ADVB
Founded
1920
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.4M
8.4M
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
CVR
ADVB
Price
$14.53
$0.35
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
10.2K
1.2M
Earning Date
02-08-2026
02-03-2026
Dividend Yield
0.85%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$26,008,045.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.15
$0.28
52 Week High
$16.64
$4.10

Technical Indicators

Market Signals
Indicator
CVR
ADVB
Relative Strength Index (RSI) 69.88 44.72
Support Level $13.02 $0.28
Resistance Level $14.25 $0.36
Average True Range (ATR) 0.82 0.04
MACD -0.06 0.00
Stochastic Oscillator 98.43 56.85

Price Performance

Historical Comparison
CVR
ADVB

About CVR Chicago Rivet & Machine Co.

Chicago Rivet & Machine Co is in the fastener industry in North America. The company operates in two segments namely fasteners and assembly equipment. Its fastener segment consists of the manufacture and sale of rivets, cold-formed fasteners, parts, and screw machine products. The assembly equipment segment consists mainly of the manufacture of automatic rivet setting machines, automatic assembly equipment, and parts and tools for such machines. The majority of revenue is from the fastener segment.

About ADVB Advanced Biomed Inc.

Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.

Share on Social Networks: